Biliary Cirrhosis happens when the bile ducts, which carry fluid from your liver, get blocked or damaged over a long time. This blockage can be caused by different things, like inflammation or a tumor. The liver tries to fix the problem by making scar tissue, which can eventually lead to cirrhosis, a serious condition where the liver can't function properly.
Every report comes from a Lived member, sent anonymously.
Have you tried Ursodiol for Biliary Cirrhosis?
Biliary cirrhosis is scarring of the liver that develops when bile cannot drain properly. Bile is a digestive fluid the liver makes and sends through a network of small and large ducts to the intestine. When that flow is blocked for a long time, bile builds up, injures liver cells and is gradually replaced by scar tissue. As scarring advances, the liver works less well and blood has a harder time passing through it. The term covers two quite different conditions. Primary biliary cholangitis (PBC) is a long-term autoimmune disease in which the immune system slowly destroys the tiny bile ducts inside the liver. It used to be called primary biliary cirrhosis, but it was renamed because most people are now diagnosed years before any cirrhosis develops. Secondary biliary cirrhosis is caused by a prolonged blockage of the larger bile ducts, for example by a narrowed duct or stones, and is a consequence of that blockage rather than a disease of its own. PBC often causes no symptoms when it is first found. When symptoms occur, tiredness and itchy skin are the most common, sometimes with dry eyes and mouth or discomfort under the right ribs. Later signs of advanced scarring include yellowing of the skin and eyes (jaundice), fluid swelling in the legs or abdomen and weight loss.
PBC is thought to arise when a person with a genetic tendency meets an environmental trigger that sets off the immune attack on the bile ducts. Suggested triggers include infections, cigarette smoking and some chemical exposures, but none has been shown to cause an individual case. Women are affected several times more often than men, and it is usually found in middle age. It is more likely in people with a parent or sibling who has it, and it often occurs alongside other autoimmune conditions such as thyroid disease, Sjögren's syndrome or Raynaud's. A family link raises risk only slightly; relatives do not routinely need screening. Secondary biliary cirrhosis follows months or years of partial blockage in the main bile ducts. Causes include a narrowing (stricture) of the bile duct, sometimes after an injury during gallbladder or other surgery; long-standing chronic pancreatitis squeezing the duct; bile duct stones; and tumors pressing on the ducts. Repeated bile duct infections add to the damage.
Liver blood tests are usually the first clue. Alkaline phosphatase is a liver enzyme that rises when bile flow is impaired, so a level that stays above the normal range for months points toward a bile duct problem. For PBC, the key test is for antimitochondrial antibodies (AMA), immune proteins found in about 95% of people with the disease. A persistently raised alkaline phosphatase together with a positive AMA test, without another explanation, is usually enough to confirm PBC, even without symptoms. Some people without AMA have other PBC-specific antibodies, and a liver biopsy is reserved for unclear cases. Imaging is essential for telling the two forms apart. Ultrasound, and often a specialized MRI of the bile ducts, looks for a blockage, stones, strictures or a tumor in the larger ducts. Those findings point to a secondary cause, whereas in PBC the large ducts look normal. Once the diagnosis is made, the next question is how much scarring is present. A liver stiffness scan (elastography, an ultrasound-based measurement) and blood tests such as bilirubin, albumin and platelet count help estimate the stage and guide how closely the liver needs watching. A rising bilirubin, or a falling albumin or platelet count, suggests more advanced scarring.
For PBC, the first treatment is ursodiol (ursodeoxycholic acid, or UDCA), a bile acid taken by mouth every day. It does not cure the disease, but it improves bile flow and slows liver damage, and people whose blood tests respond well to it can live longer without needing a transplant. It is usually taken for life. After about a year, alkaline phosphatase and bilirubin are checked to see whether the response is adequate. When ursodiol does not bring those levels down enough, or cannot be tolerated, a second medicine can be added. Elafibranor (Iqirvo) and seladelpar (Livdelzi) are newer drugs that act on receptors that control how the liver makes and handles bile acids. Both were approved in 2024 because they lower alkaline phosphatase; studies have not yet shown that they extend survival or prevent liver failure. They are not recommended once cirrhosis has caused complications such as fluid buildup or bleeding. Elafibranor can harm a developing baby, so pregnancy is ruled out before starting and birth control pills containing ethinyl estradiol need to be replaced with another method. Both elafibranor and seladelpar have been linked to bone fractures, so bone health is monitored with either. An older second-line drug, obeticholic acid (Ocaliva), was withdrawn from the US market in 2025. Itch and complications are treated alongside the disease itself. Cholestyramine, a powder that binds bile acids in the gut, is the usual first choice for itching and must be taken several hours apart from ursodiol. Other options exist when it fails. Bone density testing, calcium and vitamin D, and replacement of vitamins A, D, E and K help address the bone loss and vitamin shortfalls PBC can cause. For secondary biliary cirrhosis, the priority is relieving the blockage. This may involve stones being removed or a stent placed through an endoscope, drainage through the skin, or surgery to bypass or repair a narrowed duct. Small studies suggest that some scarring can lessen once bile drains freely again, though established cirrhosis does not fully reverse. When either form progresses to liver failure, or causes severe itch that nothing else relieves, a liver transplant can be considered.
PBC usually progresses slowly, and many people diagnosed early live for decades without developing cirrhosis, especially when ursodiol works well. The course still varies considerably. Younger age at diagnosis and a weak response to treatment are linked with faster progression. Symptoms do not track disease stage: fatigue and itching can be severe in early disease and mild in advanced disease. Fatigue does not improve with ursodiol and often needs its own plan, including attention to sleep, mood and other conditions that add to tiredness; regular exercise is safe and may help. PBC needs lifelong follow-up, with regular liver blood tests, periodic liver stiffness scans and bone density checks. If cirrhosis develops, care expands to include regular ultrasound scans to look for liver cancer and screening for enlarged veins (varices) in the esophagus that can bleed. Once cirrhosis is present, stopping alcohol completely protects the remaining liver; in earlier PBC, moderate drinking within usual safe limits is generally considered acceptable. Stopping smoking is advised because smoking is linked with more aggressive disease. Checking with the care team before starting new medicines or supplements is sensible with any liver disease. Most people with early disease can eat a normal, balanced diet. Raw shellfish and unpasteurized milk are best avoided because infections from them can be severe with liver disease. For secondary biliary cirrhosis, the outlook depends largely on the underlying cause and on whether the blockage can be relieved and kept open. Follow-up continues after treatment because a duct can narrow again.
Ask for an evaluation if liver blood tests are abnormal, especially a raised alkaline phosphatase, or if you have persistent itching, unexplained tiredness or new yellowing of the skin. If you already have PBC, discuss worsening itch, side effects from treatment or a planned pregnancy with your care team, since medicines may need to change. Contact your care team promptly about new swelling of the legs or abdomen, darker urine, worsening jaundice or muscle pain while taking elafibranor. Get emergency care right away for vomiting blood, black or bloody stools, new confusion or unusual drowsiness, or fever with chills and pain under the right ribs. If you have cirrhosis, also get emergency care for a fever above 101°F (38.3°C), or for abdominal swelling or jaundice that comes on or worsens quickly. These can signal bleeding from enlarged veins, toxins affecting the brain, an infection in blocked bile ducts or in abdominal fluid, or the liver suddenly failing, all of which need urgent treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Having been diagnosed with PBC in March 2025, I am now accepting of the disease and learning to manage it better. Fatigue has been my biggest challenge as it is constant and relentless. Fortunately, I am a responder to the medication URSODIOL and the progression of my disease has been controlled. This is a difficult disease to explain to family and friends and most assume the disease is fatty liver, or the result of alcohol abuse. Neither is true. Also, it is difficult to find a care provider that is familiar with this disease and able to offer ongoing care and treatment. I have found support groups on Facebook of other PBC patients to be very helpful. And have had to become my own best advocate in learning about my disease and the treatment protocols available.